1. The combination of the peptides Arg-Lys-Glu-Val-Tyr-OH and Arg-Lys-Asp-Val-Tyr-OH or their salts or hydrates. ! 2. The combination according to claim 1, where the peptides are contained in combination in an amount of from 30 wt.% To 70 wt.% To 70 wt.% To 30 wt.%. ! 3. The combination according to claim 1 for use in a medicinal product. ! 4. The use of the combination according to claims 1, 2 or 3 to obtain a pharmaceutical composition for the treatment and / or prevention of a malignant tumor, autoimmune diseases, fibrosis, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and blood vessels diseases and metabolic diseases . ! 5. The use of the combination according to claim 4, where the malignant tumor, autoimmune disease, fibrosis, inflammatory disease, neurodegenerative disease, infectious disease, lung disease, heart and vascular disease or metabolic disease are selected from vasculitis and excessive angiogenesis in autoimmune diseases, systemic sclerosis , multiple sclerosis, Sjogren's syndrome, vascular deformities in the networks of blood and lymph vessels, DiGeorge syndrome, congenital hemorrhagic telangiectasia, cavernous g mangiomas, cutaneous hemangiomas, lymphatic vessel deformities, graft arteriopathy, atherosclerosis, vascular anastomoses, adipose tissue in case of obesity, chronic allograft rejection, skin diseases, psoriasis, papillomas, allergic dermatitis, keloid scar, pyogenic granuloma, anorexa ulcer, AIDS, systemic sclerosis, eye diseases, persistent vitreous hyperplastic syndrome, diabetic retinopathy, premature retinopathy
展开▼